Cannabis Bioscience International Holdings, Inc.
CBIH · OTC
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 21.8% | -21.5% | 47.4% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 86.8% | 81.7% | 70.5% | 78.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $1 | $1 | $0 |
| SG&A Expenses | $0 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $1 | $1 |
| Operating Income | -$0 | -$0 | -$1 | -$1 |
| % Margin | -139.1% | -195.4% | -310.4% | -413.1% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | $0 |
| Pre-Tax Income | -$1 | -$1 | -$1 | -$1 |
| Tax Expense | $0 | $0 | -$0 | $0 |
| Net Income | -$1 | -$1 | -$1 | -$1 |
| % Margin | -181.1% | -261.8% | -325.9% | -411.7% |
| EPS | -0.051 | -0.063 | -0.1 | -0.11 |
| % Growth | 18.9% | 36.9% | 9.1% | – |
| EPS Diluted | -0.051 | -0.063 | -0.1 | -0.11 |
| Weighted Avg Shares Out | 11 | 10 | 10 | 8 |
| Weighted Avg Shares Out Dil | 11 | 10 | 10 | 8 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | -$0 | $0 | $0 |
| EBITDA | -$0 | -$0 | -$1 | -$1 |
| % Margin | -110.7% | -199.8% | -285.7% | -388% |